Biotech Outsourcing Strategies (BOS) Manchester 2026
Your integrated CDMO, CRO, and bioprocessing partner of choice, helping streamline and speed up drug development programs from early development through clinical supply and beyond.
November 24–25, 2026 | Manchester Central | Booth 19
About BOS Manchester 2026
Join us at BOS Manchester 2026, a leading event dedicated to advancing relationships between pharma and biotech companies and their outsourcing partners. This two-day forum is designed to foster meaningful connections across the drug development continuum, bringing together the right people to help move the industry forward.
BOS events unite key stakeholders across R&D outsourcing to share experiences, strengthen existing partnerships, and establish new buyer–supplier relationships for the future. The 2026 program will focus on early development-stage CMC outsourcing for both small molecules and biologics, in addition to novel therapeutic entities.
Event details
Date: November 24–25, 2026
Format: In-person
Location: Manchester Central, Manchester, England
Booth Number: 19
Event Website: BOS Manchester 2026
Why Thermo Fisher Scientific?
Early development sets the stage for the success of drug development programs across APIs, OSD, softgels, steriles, and biologics. Decisions made at this stage can significantly impact the trajectory of your program—and how quickly you reach the market. At BOS Manchester 2026, Thermo Fisher Scientific will showcase our Accelerator™ Drug Development, 360° CDMO and CRO services and solutions.
Through Accelerator Drug Development, we help streamline and speed up early development, reducing timelines and minimizing risk through cross-functional expertise and end-to-end offerings. Our global network of development and manufacturing sites also provides connected capabilities worldwide, enabling you to scale your program as needed while working with one trusted partner.
Let’s connect at BOS Manchester 2026
Visit booth 19 at BOS Manchester 2026 to learn how Accelerator Drug Development can help streamline and speed up early development across APIs, OSD, softgels, steriles, and biologics.
Together, we can help support your aspiration of getting treatments to patients faster.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon